Raffa Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.89K Buy
269
+61
+29% +$1.08K ﹤0.01% 591
2026
Q2
$3.33K Sell
208
-65
-24% -$1.08K ﹤0.01% 699
2026
Q1
$5.06K Hold
273
– – ﹤0.01% 532
2025
Q4
$4.26K Hold
273
– – ﹤0.01% 549
2025
Q3
$4K Hold
273
– – ﹤0.01% 527
2025
Q2
$4.22K Hold
273
– – ﹤0.01% 537
2025
Q1
$4.06K Hold
273
– – ﹤0.01% 464
2024
Q4
$3.62K Hold
273
– – ﹤0.01% 516
2024
Q3
$3.88K Hold
273
– – ﹤0.01% 468
2024
Q2
$3.53K Hold
273
– – ﹤0.01% 597
2024
Q1
$3.79K Hold
273
– – ﹤0.01% 556
2023
Q4
$3.9K Hold
273
– – ﹤0.01% 443
2023
Q3
$4.22K Hold
273
– – ﹤0.01% 411
2023
Q2
$4.29K Hold
273
– – ﹤0.01% 419
2023
Q1
$4.5K Hold
273
– – ﹤0.01% 426
2022
Q4
$4.26K Hold
273
– – ﹤0.01% 417
2022
Q3
$3.54K Hold
273
– – ﹤0.01% 460
2022
Q2
$3.83K Sell
273
-16
-6% -$228 ﹤0.01% 450
2022
Q1
$4.14K Buy
289
+16
+6% +$235 ﹤0.01% 450
2021
Q4
$3.72K Sell
273
-42
-13% -$589 ﹤0.01% 501
2021
Q3
$5.16K Hold
315
– – ﹤0.01% 369
2021
Q2
$5.3K Sell
315
-66
-17% -$1.12K ﹤0.01% 371
2021
Q1
$6.96K Sell
381
-8
-2% -$144 ﹤0.01% 335
2020
Q4
$7.08K Buy
389
+183
+89% +$3.21K ﹤0.01% 297
2020
Q3
$3.68K Sell
206
-66
-24% -$1.2K ﹤0.01% 379
2020
Q2
$4.88K Buy
272
+130
+92% +$2.33K ﹤0.01% 319
2020
Q1
$2.16K Buy
+142
New +$2.57K ﹤0.01% 415

Other funds holding TAK

Raffa Wealth Management's TAK Position: Q3 2026 in Review

Raffa Wealth Management increased its Takeda Pharmaceutical (TAK) stake by 29% in Q3 2026, buying an estimated $1.08K and bringing the position to 269 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Raffa Wealth Management first reported a position in TAK in Q1 2020 and has held it in 27 quarters since. The position peaked at $7.08K in Q4 2020. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Raffa Wealth Management held 269 shares of Takeda Pharmaceutical worth $4.89K as of Q3 2026.
  • Raffa Wealth Management bought 61 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.08K.
  • Takeda Pharmaceutical made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #591 holding.
  • Raffa Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2020 and has held it in 27 quarters since.
  • Raffa Wealth Management's Takeda Pharmaceutical position peaked at $7.08K in Q4 2020.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.